サンプル依頼リスト カート
  • English
市場調査レポート
商品コード
1643992

凍結乾燥注射剤の世界市場：2033年までの機会と戦略

Lyophilized Injectable Drugs Global Market Opportunities And Strategies To 2033

出版日
ページ情報
英文 305 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
凍結乾燥注射剤の世界市場：2033年までの機会と戦略
出版日: 2025年01月27日
発行: The Business Research Company
ページ情報: 英文 305 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の凍結乾燥注射剤市場は2018年に34億4,200万米ドルと評価され、2023年までCAGR2.00％以上で成長しました。

個別化医療に対する需要の増加

個別化医療に対する需要の増加は、凍結乾燥注射剤市場の成長を促進しました。個別化医療は、精密医療や個別化医療とも呼ばれ、各患者の特性に合わせた治療や介入を目指す医療へのアプローチです。個別化医療へのシフトは、カスタマイズされたバイオ医薬品の需要を増加させました。凍結乾燥は、生物学的製剤やバイオテクノロジーに基づく治療法の安定性と保存性を高め、保存するために不可欠となりました。このプロセスにより、個別化治療が流通・保管中も有効であることが保証されるため、高度な患者個別化治療のニーズを満たす凍結乾燥サービスの成長が促進されます。例えば、2022年10月、米国を拠点とし、科学者、患者、医療提供者を代表し、患者と医療制度に利益をもたらす個別化医療の理解と普及を推進する組織である個別化医療連合によると、複数の種類のがん、遺伝的希少疾患、さまざまな慢性疾患や感染症を患う人々のために、75,000を超える遺伝子検査製品と300の個別化医薬品が市場に出回っていると推定しています。さらに、個別化医療連合（PMC）によると、2022年に米国食品医薬品局が承認した新薬の34％を個別化医療が占め、過去8年間はいずれも承認の25％以上を個別化医療が占めています。したがって、個別化医療に対する需要の増加は、歴史的な期間における凍結乾燥注射剤市場の成長を支えました。

目次

第1章 エグゼクティブサマリー

  • 凍結乾燥注射剤-市場の魅力とマクロ経済情勢

第2章 目次

第3章 表一覧

第4章 図一覧

第5章 レポート構成

第6章 市場の特徴

  • 一般的な市場の定義
  • 概要
  • 凍結乾燥注射剤市場定義とセグメンテーション
  • パッケージタイプ別の市場セグメンテーション
    • 特殊包装
    • ポイントオブケア再構成
    • 使い捨てバイアル
    • その他のパッケージタイプ
  • デリバリータイプ別の市場セグメンテーション
    • シングルステップデバイス
    • マルチステップデバイス
    • 充填済み希釈液シリンジ
    • 独自の再構成デバイス
  • 適応症別の市場セグメンテーション
    • 腫瘍学
    • 感染症
    • 自己免疫疾患
    • 代謝状態
    • その他の適応症
  • エンドユーザー別の市場セグメンテーション
    • 病院
    • 外来手術センター（ASC）
    • 専門クリニック
    • その他のエンドユーザー

第7章 主要な市場動向

  • 凍結乾燥医薬品用ガラス充填式注射器の発売に注力
  • 凍結乾燥注射剤のドラッグデリバリーシステムの進歩
  • 滅菌注射薬製造の自動化により、医薬品生産の効率と拡張性が向上

第8章 凍結乾燥注射剤市場- マクロ経済シナリオ

  • COVID-19の影響：凍結乾燥注射剤市場
  • ウクライナ戦争の影響：凍結乾燥注射剤市場
  • 高インフレの影響：凍結乾燥注射剤市場

第9章 世界の市場規模と成長

  • 市場規模
  • 市場成長実績、2018-2023
    • 市場促進要因、2018-2023
    • 市場抑制要因、2018-2023
  • 市場成長予測、2023-2028、2033F
    • 市場促進要因、2023-2028
    • 市場抑制要因、2023-2028

第10章 世界の凍結乾燥注射剤市場：セグメンテーション

  • 世界の凍結乾燥注射剤市場：パッケージングタイプ別、実績と予測, 2018-2023, 2028F, 2033F
  • 世界の凍結乾燥注射剤市場：適応症別、実績と予測, 2018-2023, 2028F, 2033F
  • 世界の凍結乾燥注射剤市場：エンドユーザー別、実績と予測, 2018-2023, 2028F, 2033F
  • 世界の凍結乾燥注射剤市場：デリバリータイプ別、実績と予測, 2018-2023, 2028F, 2033F

第11章 凍結乾燥注射剤市場：地域・国別分析

  • 世界の凍結乾燥注射剤市場：地域別、実績と予測, 2018-2023, 2028F, 2033F
  • 世界の凍結乾燥注射剤市場：国別、実績と予測, 2018-2023, 2028F, 2033F

第12章 アジア太平洋市場

第13章 西欧市場

第14章 東欧市場

第15章 北米市場

第16章 南米市場

第17章 中東市場

第18章 アフリカ市場

第19章 競合情勢と企業プロファイル

  • 企業プロファイル
  • Novartis AG
  • Pfizer Inc
  • Sanofi S.A.
  • Baxter International Inc.
  • Hikma Pharmaceuticals plc

第20章 その他の大手企業と革新的企業

  • Cipla Limited
  • CordenPharma International GmbH
  • F. Hoffmann-La Roche Ltd
  • Bristol Myers Squibb Co
  • Vetter Pharma International GmbH
  • Aristopharma Limited
  • Zydus Group
  • Accord Healthcare Ltd
  • Qilu Pharmaceutical Co Ltd
  • Astellas Pharma Inc
  • Jubilant HollisterStier LLC
  • Antares Pharma Inc
  • Gilead Sciences Inc
  • Ciron Drugs & Pharmaceuticals Pvt. Ltd
  • AptarGroup Inc

第21章 競合ベンチマーキング

第22章 競合ダッシュボード

第23章 主要な合併と買収

  • Great Point Partners Acquired Lyocontract Gmbh
  • Hikma Pharmaceuticals PLC Acquired Xellia Pharmaceuticals
  • Sharp Acquired Berkshire Sterile Manufacturing
  • Recipharm AB Acquired Arranta Bio And Vibalogics

第24章 機会と戦略

  • 世界の凍結乾燥注射剤市場2028：新たな機会を提供する国
  • 世界の凍結乾燥注射剤市場2028：新たな機会を提供するセグメント
  • 世界の凍結乾燥注射剤市場2028：成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第25章 凍結乾燥注射剤市場：結論と提言

  • 結論
  • 提言
    • 製品
    • 場所
    • 価格
    • プロモーション
    • 人々

第26章 付録

目次
Product Code: o&s1455

Lyophilized injectable drugs are pharmaceutical formulations processed through lyophilization, a freeze-drying technique that removes water or solvent under low temperature and pressure. This method ensures the stability of active pharmaceutical ingredients (APIs) that might otherwise degrade in liquid form. Lyophilization is widely used for drugs requiring a long shelf life, especially biologics like monoclonal antibodies, vaccines and enzymes, which are sensitive to environmental conditions.

The lyophilized injectable drugs market consists of sales, by entities (organizations, sole traders and partnerships), of freeze-dried pharmaceutical formulations reconstituted for injection, including biologics, vaccines and small molecule drugs.

The global lyophilized injectable drugs market was valued at $3,442.00 million in 2018 which grew till 2023 at a compound annual growth rate (CAGR) of more than 2.00%.

Increasing Demand For Personalized Medicine

The increasing demand for personalized medicine propelled the growth of the lyophilized injectable drugs market. Personalized medicine, also known as precision medicine or individualized medicine, is an approach to medical care that aims to tailor treatments and interventions to the specific characteristics of each patient. The shift toward personalized medicine increased demand for customized biopharmaceuticals. Lyophilization became essential for preserving biologic or biotechnology-based treatments therapies, by enhancing their stability and shelf life. This process ensures that personalized treatments remain effective during distribution and storage, thus driving the growth of lyophilization services to meet the needs of advanced, patient-specific therapies. For instance, in October 2022, according to the Personalized Medicine Coalition, a US-based organization that represents scientists, patients and providers, promoting the understanding and adoption of personalized medicine to benefit patients and the healthcare system, estimated that more than 75,000 genetic testing products and 300 personalized medicines were on the market for people with multiple types of cancers, genetic rare diseases and a range of chronic and infectious diseases. Additionally, according to the Personalized Medicine Coalition (PMC), personalized medicines accounted for 34% of new drug approvals by the US Food and Drug Administration in 2022 and have accounted for at least 25% of approvals in each of the previous eight years. Therefore, increasing demand for personalized medicine supported the growth of the lyophilized injectable drugs market during the historic period.

Focus On Launch Of In Glass Prefillable Syringes For Lyophilized Drugs

Major companies operating in the lyophilized injectable drugs market are focused on the development advanced products, such as a glass prefillable syringe, for meeting patient needs. The glass prefillable syringe is a specialized injection system for lyophilized injectable drugs, ensuring accurate delivery and preserving the stability of biologic formulations. In September 2024, Becton, Dickinson and Company, US-based pharmaceutical company, launched BD Neopak XtraFlow. This advanced syringe is specifically designed to enhance the subcutaneous administration of biologic drugs, particularly those with higher viscosity, which often includes lyophilized formulations. It is equipped with an 8-millimeter needle and a thinner wall cannula, reducing both the injection force and time, which enhances user comfort for both patients and healthcare providers. This syringe is part of BD's commitment to meeting the increasing demand for biologic therapies, providing pharmaceutical developers with a solution that effectively handles challenging drug viscosities while streamlining the injection process.

The global lyophilized injectable drugs market is fairly fragmented, with a large number of players operating in the market. The top ten competitors in the market made up 22.77% of the total market in 2023.

Lyophilized Injectable Drugs Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global lyophilized injectable drugs market as it emerges from the COVID-19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for lyophilized injectable drugs? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The lyophilized injectable drugs market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider lyophilized injectable drugs market; and compares it with other markets.

The report covers the following chapters

  • Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by packaging type, by type of delivery, by indication and by end user.
  • Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
  • Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the lyophilized injectable drugs market.
  • Global Market Size And Growth- Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional And Country Analysis- Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
  • Market Segmentation- Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by packaging type, by type of delivery, by indication and by end user in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
  • Regional Market Size and Growth- Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
  • Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
  • Other Major And Innovative Companies Details on the company profiles of other major and innovative companies in the market.
  • Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
  • Competitive Dashboard- Briefs on competitive dashboard of major players.
  • Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
  • Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
  • Conclusions And Recommendations- This section includes recommendations for lyophilized injectable drugs providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
  • Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

  • 1) By Packaging Type: Specialty Packaging; Point-Of-Care Reconstitution; Single-Use Vials; Other Packaging Types
  • 2) By Type Of Delivery: Single-Step Devices; Multi-Step Devices; Prefilled Diluent Syringes; Proprietary Reconstitution Devices
  • 3) By Indication: Oncology; Infectious Diseases; Autoimmune Diseases; Metabolic Conditions; Other Indications
  • 4) By End-User: Hospitals; Ambulatory Surgery Centers (ASCs); Specialty Clinics; Other End-Users
  • Companies Mentioned: Novartis AG; Pfizer Inc.; Sanofi SA; Baxter International Inc.; Hikma Pharmaceuticals plc
  • Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; UK; Italy; Spain; Russia
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time-series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; lyophilized injectable drugs indicators comparison.
  • Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

  • 1.1 Lyophilized Injectable Drugs - Market Attractiveness And Macro economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

  • 6.1 General Market Definition
  • 6.2 Summary
  • 6.3 Lyophilized Injectable Drugs Market Definition And Segmentations
  • 6.4 Market Segmentation By Packaging Type
    • 6.4.1 Specialty Packaging
    • 6.4.2 Point-Of-Care Reconstitution
    • 6.4.3 Single-Use Vials
    • 6.4.4 Other Packaging Types
  • 6.5 Market Segmentation By Type Of Delivery
    • 6.5.1 Single-Step Devices
    • 6.5.2 Multi-Step Devices
    • 6.5.3 Prefilled Diluent Syringes
    • 6.5.4 Proprietary Reconstitution Devices
  • 6.6 Market Segmentation By Indication
    • 6.6.1 Oncology
    • 6.6.2 Infectious Diseases
    • 6.6.3 Autoimmune Diseases
    • 6.6.4 Metabolic Conditions
    • 6.6.5 Other Indications
  • 6.7 Market Segmentation By End-User
    • 6.7.1 Hospitals
    • 6.7.2 Ambulatory Surgery Centers (ASCs)
    • 6.7.3 Specialty Clinics
    • 6.7.4 Other End-Users

7 Major Market Trends

  • 7.1 Focus On Launch Of In Glass Prefillable Syringes For Lyophilized Drugs
  • 7.2 Advancements In Drug Delivery Systems For Lyophilized Injectable Drugs
  • 7.3 Automation In Sterile Injectable Drug Manufacturing Improving Efficiency And Scalability In Drug Production

8 Lyophilized Injectable Drugs Market - Macro-Economic Scenario

  • 8.1 COVID-19 Impact On The Lyophilized Injectable Drugs Market
  • 8.2 Impact Of The War In Ukraine On The Lyophilized Injectable Drugs Market
  • 8.3 Impact Of High Inflation On The Lyophilized Injectable Drugs Market

9 Global Market Size And Growth

  • 9.1 Market Size
  • 9.2 Historic Market Growth, 2018 - 2023, Value ($ Million)
    • 9.2.1 Market Drivers 2018 - 2023
    • 9.2.2 Market Restraints 2018 - 2023
  • 9.3 Forecast Market Growth, 2023 - 2028, 2033F Value ($ Million)
    • 9.3.1 Market Drivers 2023 - 2028
    • 9.3.2 Market Restraints 2023 - 2028

10 Global Lyophilized Injectable Drugs Market Segmentation

  • 10.1 Global Lyophilized Injectable Drugs Market, Segmentation By Packaging Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.2 Global Lyophilized Injectable Drugs Market, Segmentation By Indication, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.3 Global Lyophilized Injectable Drugs Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.4 Global Lyophilized Injectable Drugs Market, Segmentation By Type of Delivery, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

11 Lyophilized Injectable Drugs Market, Regional and Country Analysis

  • 11.1 Global Lyophilized Injectable Drugs Market, By Region, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 11.2 Global Lyophilized Injectable Drugs Market, By Country, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

12 Asia-Pacific Market

  • 12.1 Summary
    • 12.1.1 Market Overview
    • 12.1.2 Region Information
    • 12.1.3 Market Information
    • 12.1.4 Background Information
    • 12.1.5 Government Initiatives
    • 12.1.6 Regulations
    • 12.1.7 Regulatory Bodies
    • 12.1.8 Major Associations
    • 12.1.9 Taxes Levied
    • 12.1.10 Corporate Tax Structure
    • 12.1.11 Investments
    • 12.1.12 Major Companies
  • 12.2 Asia-Pacific Lyophilized Injectable Drugs Market, Segmentation By Packaging Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.3 Asia-Pacific Lyophilized Injectable Drugs Market, Segmentation By Indication, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.4 Asia-Pacific Lyophilized Injectable Drugs Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.5 Asia-Pacific Lyophilized Injectable Drugs Market: Country Analysis
  • 12.6 China Market
  • 12.7 Summary
    • 12.7.1 Market Overview
    • 12.7.2 Country Information
    • 12.7.3 Market Information
    • 12.7.4 Background Information
    • 12.7.5 Government Initiatives
    • 12.7.6 Regulations
    • 12.7.7 Regulatory Bodies
    • 12.7.8 Major Associations
    • 12.7.9 Taxes Levied
    • 12.7.10 Corporate Tax Structure
    • 12.7.11 Investments
    • 12.7.12 Major Companies
  • 12.8 China Lyophilized Injectable Drugs Market, Segmentation By Packaging Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.9 China Lyophilized Injectable Drugs Market, Segmentation By Indication, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.10 China Lyophilized Injectable Drugs Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.11 India Market
  • 12.12 India Lyophilized Injectable Drugs Market, Segmentation By Packaging Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.13 India Lyophilized Injectable Drugs Market, Segmentation By Indication, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.14 India Lyophilized Injectable Drugs Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.15 Japan Market
  • 12.16 Japan Lyophilized Injectable Drugs Market, Segmentation By Packaging Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.17 Japan Lyophilized Injectable Drugs Market, Segmentation By Indication, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.18 Japan Lyophilized Injectable Drugs Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.19 Australia Market
  • 12.20 Australia Lyophilized Injectable Drugs Market, Segmentation By Packaging Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.21 Australia Lyophilized Injectable Drugs Market, Segmentation By Indication, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.22 Australia Lyophilized Injectable Drugs Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.23 Indonesia Market
  • 12.24 Indonesia Lyophilized Injectable Drugs Market, Segmentation By Packaging Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.25 Indonesia Lyophilized Injectable Drugs Market, Segmentation By Indication, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.26 Indonesia Lyophilized Injectable Drugs Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.27 South Korea Market
  • 12.28 South Korea Lyophilized Injectable Drugs Market, Segmentation By Packaging Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.29 South Korea Lyophilized Injectable Drugs Market, Segmentation By Indication, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.30 South Korea Lyophilized Injectable Drugs Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

13 Western Europe Market

  • 13.1 Summary
    • 13.1.1 Market Overview
    • 13.1.2 Region Information
    • 13.1.3 Market Information
    • 13.1.4 Background Information
    • 13.1.5 Government Initiatives
    • 13.1.6 Regulations
    • 13.1.7 Regulatory Bodies
    • 13.1.8 Major Associations
    • 13.1.9 Taxes Levied
    • 13.1.10 Corporate tax structure
    • 13.1.11 Investments
    • 13.1.12 Major Companies
  • 13.2 Western Europe Lyophilized Injectable Drugs Market, Segmentation By Packaging Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.3 Western Europe Lyophilized Injectable Drugs Market, Segmentation By Indication, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.4 Western Europe Lyophilized Injectable Drugs Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.5 Western Europe Lyophilized Injectable Drugs Market: Country Analysis
  • 13.6 UK Market
  • 13.7 UK Lyophilized Injectable Drugs Market, Segmentation By Packaging Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.8 UK Lyophilized Injectable Drugs Market, Segmentation By Indication, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.9 UK Lyophilized Injectable Drugs Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.10 Germany Market
  • 13.11 Germany Lyophilized Injectable Drugs Market, Segmentation By Packaging Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.12 Germany Lyophilized Injectable Drugs Market, Segmentation By Indication, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.13 Germany Lyophilized Injectable Drugs Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.14 France Market
  • 13.15 France Lyophilized Injectable Drugs Market, Segmentation By Packaging Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.16 France Lyophilized Injectable Drugs Market, Segmentation By Indication, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.17 France Lyophilized Injectable Drugs Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.18 Italy Market
  • 13.19 Italy Lyophilized Injectable Drugs Market, Segmentation By Packaging Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.20 Italy Lyophilized Injectable Drugs Market, Segmentation By Indication, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.21 Italy Lyophilized Injectable Drugs Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.22 Spain Market
  • 13.23 Spain Lyophilized Injectable Drugs Market, Segmentation By Packaging Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.24 Spain Lyophilized Injectable Drugs Market, Segmentation By Indication, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.25 Spain Lyophilized Injectable Drugs Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

14 Eastern Europe Market

  • 14.1 Summary
    • 14.1.1 Market Overview
    • 14.1.2 Region Information
    • 14.1.3 Market Information
    • 14.1.4 Background Information
    • 14.1.5 Government Initiatives
    • 14.1.6 Regulations
    • 14.1.7 Regulatory Bodies
    • 14.1.8 Major Associations
    • 14.1.9 Taxes Levied
    • 14.1.10 Corporate Tax Structure
    • 14.1.11 Investments
    • 14.1.12 Major companies
  • 14.2 Eastern Europe Lyophilized Injectable Drugs Market, Segmentation By Packaging Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.3 Eastern Europe Lyophilized Injectable Drugs Market, Segmentation By Indication, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.4 Eastern Europe Lyophilized Injectable Drugs Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.5 Eastern Europe Lyophilized Injectable Drugs Market: Country Analysis
  • 14.6 Russia Market
  • 14.7 Russia Lyophilized Injectable Drugs Market, Segmentation By Packaging Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.8 Russia Lyophilized Injectable Drugs Market, Segmentation By Indication, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.9 Russia Lyophilized Injectable Drugs Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

15 North America Market

  • 15.1 Summary
    • 15.1.1 Market Overview
    • 15.1.2 Region Information
    • 15.1.3 Market Information
    • 15.1.4 Background Information
    • 15.1.5 Government Initiatives
    • 15.1.6 Regulations
    • 15.1.7 Regulatory Bodies
    • 15.1.8 Major Associations
    • 15.1.9 Taxes Levied
    • 15.1.10 Corporate Tax Structure
    • 15.1.11 Investments
    • 15.1.12 Major Companies
  • 15.2 North America Lyophilized Injectable Drugs Market, Segmentation By Packaging Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.3 North America Lyophilized Injectable Drugs Market, Segmentation By Indication, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.4 North America Lyophilized Injectable Drugs Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.5 North America Lyophilized Injectable Drugs Market: Country Analysis
  • 15.6 USA Market
  • 15.7 Summary
    • 15.7.1 Market Overview
    • 15.7.2 Country Information
    • 15.7.3 Market Information
    • 15.7.4 Background Information
    • 15.7.5 Government Initiatives
    • 15.7.6 Regulations
    • 15.7.7 Regulatory Bodies
    • 15.7.8 Major Associations
    • 15.7.9 Taxes Levied
    • 15.7.10 Corporate Tax Structure
    • 15.7.11 Investments
    • 15.7.12 Major Companies
  • 15.8 USA Lyophilized Injectable Drugs Market, Segmentation By Packaging Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.9 USA Lyophilized Injectable Drugs Market, Segmentation By Indication, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.10 USA Lyophilized Injectable Drugs Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.11 Canada Market
  • 15.12 Canada Lyophilized Injectable Drugs Market, Segmentation By Packaging Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.13 Canada Lyophilized Injectable Drugs Market, Segmentation By Indication, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.14 Canada Lyophilized Injectable Drugs Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

16 South America Market

  • 16.1 Summary
    • 16.1.1 Market Overview
    • 16.1.1 Region Information
    • 16.1.2 Market Information
    • 16.1.3 Background Information
    • 16.1.4 Government Initiatives
    • 16.1.5 Regulations
    • 16.1.6 Regulatory Bodies
    • 16.1.7 Major Associations
    • 16.1.8 Taxes Levied
    • 16.1.9 Corporate Tax Structure
    • 16.1.10 Investments
    • 16.1.11 Major Companies
  • 16.2 South America Lyophilized Injectable Drugs Market, Segmentation By Packaging Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.3 South America Lyophilized Injectable Drugs Market, Segmentation By Indication, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.4 South America Lyophilized Injectable Drugs Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.5 Brazil Market
  • 16.6 Brazil Lyophilized Injectable Drugs Market, Segmentation By Packaging Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.7 Brazil Lyophilized Injectable Drugs Market, Segmentation By Indication, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.8 Brazil Lyophilized Injectable Drugs Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

17 Middle East Market

  • 17.1 Summary
    • 17.1.1 Market Overview
    • 17.1.2 Region Information
    • 17.1.3 Market Information
    • 17.1.4 Background Information
    • 17.1.5 Government Initiatives
    • 17.1.6 Regulations
    • 17.1.7 Regulatory Bodies
    • 17.1.8 Major Associations
    • 17.1.9 Taxes Levied
    • 17.1.10 Corporate Tax Structure
    • 17.1.11 Investments
    • 17.1.12 Major Companies
  • 17.2 Middle East Lyophilized Injectable Drugs Market, Segmentation By Packaging Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 17.3 Middle East Lyophilized Injectable Drugs Market, Segmentation By Indication, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 17.4 Middle East Lyophilized Injectable Drugs Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

18 Africa Market

  • 18.1 Summary
    • 18.1.1 Market Overview
    • 18.1.2 Region Information
    • 18.1.3 Market Information
    • 18.1.4 Background Information
    • 18.1.5 Government Initiatives
    • 18.1.6 Regulations
    • 18.1.7 Regulatory Bodies
    • 18.1.8 Major Associations
    • 18.1.9 Taxes Levied
    • 18.1.10 Corporate Tax Structure
    • 18.1.11 Investments
    • 18.1.12 Major Companies
  • 18.2 Africa Lyophilized Injectable Drugs Market, Segmentation By Packaging Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 18.3 Africa Lyophilized Injectable Drugs Market, Segmentation By Indication, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 18.4 Africa Lyophilized Injectable Drugs Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

19 Competitive Landscape And Company Profiles

  • 19.1 Company Profiles
  • 19.2 Novartis AG
    • 19.2.1 Company Overview
    • 19.2.2 Products And Services
    • 19.2.3 Business Strategy
    • 19.2.4 Financial Overview
  • 19.3 Pfizer Inc
    • 19.3.1 Company Overview
    • 19.3.2 Products And Services
    • 19.3.3 Business Strategy
    • 19.3.4 Financial Overview
  • 19.4 Sanofi S.A.
    • 19.4.1 Company Overview
    • 19.4.2 Products And Services
    • 19.4.3 Business Strategy
    • 19.4.4 Financial Overview
  • 19.5 Baxter International Inc.
    • 19.5.1 Company Overview
    • 19.5.2 Products And Services
    • 19.5.3 Business Strategy
    • 19.5.4 Financial Overview
  • 19.6 Hikma Pharmaceuticals plc
    • 19.6.1 Company Overview
    • 19.6.2 Products And Services
    • 19.6.3 Business Strategy
    • 19.6.4 Financial Overview

20 Other Major And Innovative Companies

  • 20.1 Cipla Limited
    • 20.1.1 Company Overview
    • 20.1.2 Products And Services
  • 20.2 CordenPharma International GmbH
    • 20.2.1 Company Overview
    • 20.2.2 Products And Services
  • 20.3 F. Hoffmann-La Roche Ltd
    • 20.3.1 Company Overview
    • 20.3.2 Products And Services
  • 20.4 Bristol Myers Squibb Co
    • 20.4.1 Company Overview
    • 20.4.2 Products And Services
  • 20.5 Vetter Pharma International GmbH
    • 20.5.1 Company Overview
    • 20.5.2 Products And Services
  • 20.6 Aristopharma Limited
    • 20.6.1 Company Overview
    • 20.6.2 Products And Services
  • 20.7 Zydus Group
    • 20.7.1 Company Overview
    • 20.7.2 Products And Services
  • 20.8 Accord Healthcare Ltd
    • 20.8.1 Company Overview
    • 20.8.2 Products And Services
  • 20.9 Qilu Pharmaceutical Co Ltd
    • 20.9.1 Company Overview
    • 20.9.2 Products And Services
  • 20.10 Astellas Pharma Inc
    • 20.10.1 Company Overview
    • 20.10.2 Products And Services
  • 20.11 Jubilant HollisterStier LLC
    • 20.11.1 Company Overview
    • 20.11.2 Products And Services
  • 20.12 Antares Pharma Inc
    • 20.12.1 Company Overview
    • 20.12.2 Products And Services
  • 20.13 Gilead Sciences Inc
    • 20.13.1 Company Overview
    • 20.13.2 Products And Services
  • 20.14 Ciron Drugs & Pharmaceuticals Pvt. Ltd
    • 20.14.1 Company Overview
    • 20.14.2 Products And Services
  • 20.15 AptarGroup Inc
    • 20.15.1 Company Overview
    • 20.15.2 Products And Services

21 Competitive Benchmarking

22 Competitive Dashboard

23 Key Mergers And Acquisitions

  • 23.1 Great Point Partners Acquired Lyocontract Gmbh
  • 23.2 Hikma Pharmaceuticals PLC Acquired Xellia Pharmaceuticals
  • 23.3 Sharp Acquired Berkshire Sterile Manufacturing
  • 23.4 Recipharm AB Acquired Arranta Bio And Vibalogics

24 Opportunities And Strategies

  • 24.1 Global Lyophilized Injectable Drugs Market In 2028 - Countries Offering Most New Opportunities
  • 24.2 Global Lyophilized Injectable Drugs Market In 2028 - Segments Offering Most New Opportunities
  • 24.3 Global Lyophilized Injectable Drugs Market In 2028 - Growth Strategies
    • 24.3.1 Market Trend Based Strategies
    • 24.3.2 Competitor Strategies

25 Lyophilized Injectable Drugs Market, Conclusions And Recommendations

  • 25.1 Conclusions
  • 25.2 Recommendations
    • 25.2.1 Product
    • 25.2.2 Place
    • 25.2.3 Price
    • 25.2.4 Promotion
    • 25.2.5 People

26 Appendix

  • 26.1 Geographies Covered
  • 26.2 Market Data Sources
  • 26.3 Research Methodology
  • 26.4 Currencies
  • 26.5 The Business Research Company
  • 26.6 Copyright and Disclaimer